InflaRx NV buy Guggenheim
Start price
10.11.25
/
50%
€1.49
Target price
10.11.26
€19.03
Performance (%)
-38.10%
Price
08:42
€0.92
Summary
This prediction is currently active. The BUY prediction by Guggenheim for InflaRx NV is performing very badly with a performance of -38.10%. This prediction currently runs until 10.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| InflaRx NV | -2.467% | -2.467% |
| iShares Core DAX® | 0.224% | 2.031% |
| iShares Nasdaq 100 | 0.371% | -0.955% |
| iShares Nikkei 225® | 0.972% | -0.953% |
| iShares S&P 500 | 0.417% | -0.622% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ:IFRX) had its price target raised by analysts at Guggenheim from $10.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat